Xencor, Inc. (XNCR)
NASDAQ: XNCR · Real-Time Price · USD
7.70
+0.04 (0.59%)
Aug 15, 2025, 10:44 AM - Market open
Xencor Employees
Xencor had 250 employees as of December 31, 2024. The number of employees decreased by 30 or -10.71% compared to the previous year.
Employees
250
Change (1Y)
-30
Growth (1Y)
-10.71%
Revenue / Employee
$587,716
Profits / Employee
-$684,336
Market Cap
548.83M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 250 | -30 | -10.71% |
Dec 31, 2023 | 280 | -1 | -0.36% |
Dec 31, 2022 | 281 | 27 | 10.63% |
Dec 31, 2021 | 254 | 52 | 25.74% |
Dec 31, 2020 | 202 | 36 | 21.69% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
XNCR News
- 8 days ago - Xencor Reports Second Quarter 2025 Financial Results - Business Wire
- 14 days ago - Xencor Appoints Raymond Deshaies, Ph.D., to Board of Directors - Business Wire
- 3 months ago - Xencor Reports First Quarter 2025 Financial Results - Business Wire
- 3 months ago - Xencor Announces Positive Interim Results From First-in-Human Healthy Volunteer Study of XmAb942, a High-Potency Extended Half-Life Anti-TL1A Antibody, in Development for Treatment of Inflammatory Bowel Disease - Business Wire
- 5 months ago - Xencor Appoints Todd Simpson to Board of Directors - Business Wire
- 6 months ago - Xencor Reports Fourth Quarter and Full Year 2024 Financial Results - Business Wire
- 6 months ago - 20 stocks of companies expected to put up numbers to back investors' new ‘growth mindset' - Market Watch
- 9 months ago - Xencor to Participate at Upcoming Investor Conferences - Business Wire